D/C/F/TAF

J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK
Endpoints
Mon, 09/25/17 - 09:44 am
JNJ
HIV
Gilead
GSK
FDA
D/C/F/TAF